Market Performance
Anlon Healthcare share price has come into the spotlight as the pharmaceutical company announced the details of its upcoming initial public offering (IPO). The Rajkot-based firm has set a price band of ₹86–91 per share.
The subscription window for the IPO will begin on August 26 and close on August 29. The anchor book is scheduled to launch on August 25, while the listing of shares on the stock exchanges is expected on September 3, 2025.
Main News
The IPO includes a fresh issue of 1.33 crore equity shares. At the higher end of the price band, the total issue size is estimated to be ₹121 crore.
The proceeds from the IPO are planned to be allocated towards:
- ₹30.7 crore – expansion of manufacturing facilities
- ₹43.15 crore – working capital requirements
- Repayment of existing borrowings
- General corporate purposes
Interactive Financial Services will serve as the lead manager for the IPO.
Company Profile
Anlon Healthcare operates in the pharmaceutical sector, focusing on the production of active pharmaceutical ingredients, intermediates, and finished formulations.
The company’s peer group includes well-known names such as Kronox Lab Sciences, AMI Organics, and Supriya Lifescience.
Financial Highlights
- Revenue FY23: ₹112.9 crore
- Revenue FY24: ₹66.6 crore
- Net Profit FY23: ₹5.82 crore
- Net Profit FY24: ₹9.65 crore
- Revenue (10 months ending Jan 2025): ₹77.2 crore
- Net Profit (10 months ending Jan 2025): ₹12 crore
Although the company’s revenue declined in FY24 compared to FY23, its profitability improved significantly, reflecting stronger cost management and operational efficiency.
Summary
Anlon Healthcare share price will be a key focus for investors as the company launches its IPO on August 26. With a price band fixed at ₹86–91 per share, the issue aims to raise around ₹121 crore. Supported by steady profit growth and upcoming manufacturing expansion, Anlon Healthcare is gearing up for its stock market debut on September 3, 2025.
Easy & quick
Leave A Comment?